Encompass Health Corporation (EHC)

NYSE: EHC · USD

$122

+0.30 (+0.3%)· Recorded snapshot

Market cap	12B
Revenue (ttm)	6.2B
Net income (ttm)	619.4M
EPS (ttm)	$6.13
Shares out	98.7M
P/E (trailing)	19.9x
P/E (forward)	19.1x
Dividend	$0.84 (0.69%)
Volume	788,513
Beta	0.60

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 6.2B
Net income (ttm): 619.4M
EPS (ttm): $6.13
P/E (trailing): 19.9x
P/E (forward): 19.1x
Market cap: 12B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Mantenere

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E19.1

P25 n/aP50 n/aP75 n/a

Trailing P/E19.9

P25 n/aP50 n/aP75 n/a

ROE25

P25 n/aP50 n/aP75 n/a

ROIC14.5

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All EHC indicators

Market & fundamental data

Available fields

290

Groups with data

Currency

USD

Showing 290 of 290 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0000785161
Company name	Encompass Health Corporation
Country	United States
Country code	US
CUSIP number	29261A100
Earnings date	2026-10-28
Earnings time	amc
Employees	29,699
Employees change	1,021
Employees growth	3.56%
Enterprise value	$14.8B
Exchange	NYSE
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	1983
Industry	Medical Care Facilities
IPO date	1986-09-30
Is primary listing	Yes
Is SPAC	No
ISIN number	US29261A1007
Last 10-K release date	2026-02-26
Last earnings date	2026-10-28
Last refreshed	2026-10-28
Last stock split date	2006-10-26
Last stock split type	Reverse
Market cap	$12B
Market cap category	Large-Cap
Next earnings date	2027-02-04
Options	Yes
Price	$121.83
Price currency	USD
Sector	Healthcare
SIC code	8060
Stock price date	2026-10-28
Symbol	EHC
U.S. state	Alabama
Website	https://www.encompasshealth.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Adjusted P/E ratio	20.86x
Average P/E ratio (10Y)	19.94x
Average P/E ratio (3Y)	20.42x
Average P/E ratio (5Y)	19.75x
Earnings yield	5.03%
EV/Earnings	23.82x
EV/EBIT	13.21x
EV/EBITDA	10.08x
EV/FCF	35.69x
EV/Sales	2.38x
FCF / EV yield	2.8%
FCF yield	3.44%
Forward EV/Sales	2.19x
Forward P/E	19.08x
Forward P/S	1.79x
Graham number	60.23592
Graham upside	-50.56%
Industry forward P/E	14.81x
Industry P/E	18.21x
Lynch fair value	$62.00
Lynch upside	-49.11%
P/(FCF - SBC) ratio	33.82x
P/(OCF - SBC) ratio	10.41x
P/B ratio	4.62x
P/E ratio	19.86x
P/FCF ratio	29.07x
P/OCF ratio	9.91x
P/S ratio	1.94x
PEG ratio	1.79x
Price / tangible book value	12.42x
Price/EBITDA ratio	8.21x
Sector forward P/E	23.56x
Sector P/E	50.13x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	18%
EBITDA margin	23.58%
Effective tax rate	20.46%
FCF margin	6.66%
Gross margin	43.86%
Operating margin	18%
Pretax margin	16.56%
Profit margin	10.01%
Profit per employee	$20,856
Profitable quarters	50
Profitable years	19
Revenue per employee	$208,967
ROA	9.8%
ROA (5Y)	7.72%
ROCE	16.97%
ROE	24.97%
ROE (5Y)	21.15%
ROIC	14.52%
ROIC (5Y)	11.6%
SBC / revenue	0.93%
Tax / revenue	3.39%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	19.89%
EPS growth (Q)	10.8%
EPS growth (QoQ)	-20.4%
EPS growth 10Y	10.41%
EPS growth 3Y	25.32%
EPS growth 5Y	9.81%
EPS growth quarters	10
EPS growth years	3
FCF growth	-5.87%
FCF growth (Q)	-45.01%
FCF growth (QoQ)	-58.66%
FCF growth 3Y	62.3%
FCF growth 5Y	-0.57%
Gross profit growth	13.33%
Gross profit growth (Q)	13.42%
Gross profit growth 3Y	13.17%
Gross profit growth 5Y	8.78%
Net income growth	18.81%
Net income growth (Q)	8.3%
Net income growth (QoQ)	-20.88%
Net income growth 3Y	25.68%
Net income growth 5Y	10.11%
Net income growth quarters	7
Net income growth years	2
OCF growth	9.69%
OCF growth (Q)	4.59%
OCF growth (QoQ)	-9.74%
OCF growth 10Y	7.26%
OCF growth 3Y	21.45%
OCF growth 5Y	6.93%
Operating income growth	15.45%
Operating income growth (Q)	11.31%
Operating income growth 3Y	17.38%
Operating income growth 5Y	9.58%
Revenue growth	9.47%
Revenue growth (Q)	9.58%
Revenue growth (QoQ)	0.68%
Revenue growth 10Y	6.1%
Revenue growth 3Y	10.7%
Revenue growth 5Y	7.37%
Revenue growth quarters	16
Revenue growth years	5

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-799.1M
Depreciation and amortization	$346.5M
EBIT	$1.1B
EBITDA	$1.5B
EPS	$6.13
FCF per share	$4.19
Financing cash flow	$-390M
Free cash flow	$413.4M
Free cash flow minus SBC	$355.4M
Gross profit	$2.7B
Income taxes	$210.3M
Investing cash flow	$-826.4M
Net borrowing	$158.6M
Net cash flow	$-3.9M
Net income	$619.4M
Operating cash flow minus SBC	$1.2B
Operating income	$1.1B
Revenue	$6.2B
Stock-based compensation	$58M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	3.32
Book value per share	$26.29
Debt / EBITDA	1.87
Debt / equity	0.82
Debt / FCF	6.88
Goodwill	$1.3B
Interest coverage	8.89
Long-term assets	$6.4B
Long-term liabilities	$3.1B
Net cash (debt)	$-2.7B
Net cash / market cap	-22.75%
Net debt / EBITDA	1.87
Net debt / equity	0.79
Net debt / FCF	6.61
Piotroski F-Score	7
Property, plant and equipment	$4.5B
Shareholders' equity	$3.5B
Tangible book value	$967.4M
Tangible book value per share	$9.79
Total assets	$7.5B
Total cash	$107.7M
Total debt	$2.8B
Total liabilities	$4B
WACC	6.77%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.87
Current assets	$1B
Current liabilities	$873.4M
Current ratio	1.19
Net working capital	$123.3M
Quick ratio	0.91
Working capital	$167.6M
Working capital turnover	56.27

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	0.98%
Dividend growth	11.11%
Dividend growth (10Y)	-1.6%
Dividend growth (3Y)	10.06%
Dividend growth (5Y)	-6.51%
Dividend growth years	2
Dividend payment date	2027-01-15
Dividend payment years	14
Dividend payout frequency	Quarterly
Dividend per share	$0.84
Dividend yield	0.69%
Ex-dividend date	2027-01-04
FCF payout ratio	20.05%
Last dividend	$0.21
Payout ratio	13.7%
Shareholder yield	1.67%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	217.74%
10Y return CAGR	16.44%
10Y total return	358.06%
150-day SMA	$112.10
15Y price change	553.89%
15Y return CAGR	16.69%
15Y total return	913.21%
1D price change	0.25%
1M price change	-1.34%
1M total return	-1.17%
1W price change	0.12%
1W total return	0.12%
1Y price change	-4.21%
1Y return CAGR	-3.51%
1Y total return	-3.51%
20-day SMA	$123.26
200-day SMA	$109.71
20Y price change	397.22%
20Y return CAGR	10.75%
20Y total return	670.45%
3M price change	6.97%
3M total return	7.16%
3Y price change	100.2%
3Y return CAGR	26.93%
3Y total return	104.54%
50-day SMA	$122.35
50-day SMA vs 200-day SMA	50over200
52-week high	$129.96
52-week high date	2026-10-15
52-week low	$92.77
52-week low date	2026-02-03
5Y price change	85.56%
5Y return CAGR	19.63%
5Y total return	144.99%
6M price change	20.71%
6M total return	21.15%
All-time high	$154.06
All-time high date	1998-04-20
All-time low	$0.35
All-time low date	2003-03-31
Average true range (ATR)	$3.22
Average volume	1M
Beta (1Y)	0.58
Beta (2Y)	0.63
Beta (5Y)	0.6
Change from 52-week high	-6.26%
Change from 52-week low	31.33%
Change from all-time high	-20.93%
Change from all-time low	34,705.71%
Change from open	-0.47%
Day's gap	0.72%
Dollar volume	$96.1M
High price	$122.73
Low price	$121.70
Monthly RSI	60.27
Open price	$122.41
Position in 52-week range	12.62%
Premarket change	-2.9%
Premarket close	$121.53
Premarket price	$118.00
Previous close	$121.53
Price vs 150-day SMA	8.67%
Price vs 20-day SMA	-1.17%
Price vs 200-day SMA	11.04%
Price vs 50-day SMA	-0.43%
Relative volume	0.77
RSI	47.12
Sharpe ratio	-0.11
Sharpe ratio (3Y)	0.87
Sharpe ratio (5Y)	0.61
Sortino ratio	0.04
Sortino ratio (3Y)	1.64
Sortino ratio (5Y)	1.18
Volume	788.5K
Weekly RSI	56.55
YTD price change	14.77%
YTD total return	15.62%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	97.7M
Float percentage	98.98%
Shares change (QoQ)	-0.6%
Shares change (YoY)	-0.98%
Shares held by insiders	0.82%
Shares held by institutions	99.32%
Shares outstanding	98.7M
Short % of float	3.57%
Short % of shares	3.54%
Short ratio	4.1 days

Deeper analysis on EHC

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this EHC report

Is a complete EHC research report available?

No complete published report is available for Encompass Health Corporation (EHC) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Encompass Health Corporation (EHC)

Price

Financial snapshot

Fair-value bridge

Latest news · EHC

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All EHC indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on EHC

Frequently asked questions